Physician profile
Darrell R Pietsch
NPI 1780689992
$1,065.19
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $118 · 2021: $82.60 · 2022: $147 · 2023: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $230.36 | 2019-2021 | |
| Zoll Respicardia, INC. | $108.22 | 2023 | Remede System |
| Gilead Sciences, INC. | $95.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $80.97 | 2019 | |
| Glaxosmithkline, LLC. | $79.67 | 2019-2023 | Arexvy |
| Vital Connect, INC | $79.36 | 2023 | Vitalpatch Rtm |
| Pfizer INC. | $73.20 | 2019-2023 | |
| Perspectum Diagnostics LTD | $54.75 | 2023 | Livermultiscan |
| Janssen Pharmaceuticals, INC | $43.68 | 2019 | |
| Amarin Pharma, INC. | $30.96 | 2019 | |
| Novo Nordisk INC | $28.19 | 2022-2023 | Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.99 | 2022 | |
| Amgen INC. | $18.10 | 2019 | |
| Merck Sharp & Dohme LLC | $16.65 | 2023 | M-M-R II, Vaxneuvance, Vaxelis |
| Abbott Laboratories | $16.56 | 2023 | Freestyle Libre 3 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15.62 | 2023 | Da Vinci Surgical System |
| Ironshore Pharmaceuticals INC. | $13.61 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.98 | 2019 | |
| Allergan, INC. | $12.65 | 2019 | |
| Therapeuticsmd, INC. | $12.25 | 2019 | |
| Astellas Pharma US INC | $11.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Pietsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.